myBiometry Raises $5 Million in Oversubscribed Seed Round

Asthma and COPD diagnostic and remote monitoring firm Biometry Inc. (myBiometry) is $5 million richer these days, having raised $5 million in an oversubscribed seed funding round led by Dexcom Ventures. The company will use the funding—also supported by CareSource Indiana, Elevate Ventures, and other investor groups—to advance the development of its fenoTRACK solution, a device that provides data to enable early detection of asthma and chronic obstructive pulmonary disease (COPD) exacerbations. “We’re excited to partner with Dexcom Ventures and CareSource as we near the milestone of submitting fenoTRACK for regulatory clearance,” myBiometry CEO Bryan Nolan said. Read more >>